National Institute of General Medical Sciences; Notice of Closed Meetings, 25296-25297 [2019-11337]
Download as PDF
<![CDATA[
khammond on DSKBBV9HB2PROD with NOTICES
25296
Federal Register / Vol. 84, No. 105 / Friday, May 31, 2019 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, (301) 806–
2515, chatterm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Metabolic
Reprogramming to Improve Immunotherapy.
Date: June 27, 2019.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Svetlana Kotliarova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
Bethesda, MD 20892, 301–594–7945,
kotliars@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Investigations on Primary Immunodeficiency
Diseases.
Date: June 27, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jin Huang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4095G,
MSC 7812, Bethesda, MD 20892, 301–435–
1230, jh377p@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–18–
744: Clinical Pilot Studies in Kidney
Diseases.
Date: June 27, 2019.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Julia Spencer Barthold,
MD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–402–3073, julia.barthold@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
High Throughput Screening.
Date: June 28, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH, RKL II, 6701 Rockledge Drive,
Bethesda, MD 21892 (Virtual Meeting).
Contact Person: David Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892, 301–435–
2902, filpuladr@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Learning, Memory, Language,
Communication and Related Neurosciences.
Date: June 28, 2019.
Time: 8:00 a.m. to 6:00 p.m.
VerDate Sep<11>2014
16:42 May 30, 2019
Jkt 247001
Agenda: To review and evaluate grant
applications.
Place: Dupont Circle Hotel, 1500 New
Hampshire Ave. NW, Washington, DC 20036.
Contact Person: Susan Gillmor, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 240–
762–3076, susan.gillmor@nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; International and Cooperative
Projects—1 Study Section.
Date: June 28, 2019.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 24, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–11327 Filed 5–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the NHLBI, Mentored
Clinical and Basic Science Review
Committee, Westin Crystal City, 1800
Jefferson Davis Highway, Arlington, VA
22202 which was published in the
Federal Register on February 25, 2019,
6019.
This notice is being amended due to
hotel location change from Westin
Crystal City, Westin Crystal City, 1800
Jefferson Davis Highway, Arlington, VA
22202 to Crowne Plaza National Airport,
1480 Crystal Drive, Arlington, VA
22202. The meeting is closed to the
public.
Dated: May 24, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–11334 Filed 5–30–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIGMS R25 Innovative
Programs to Enhance Research Training
(IPERT) Applications.
Date: July 11, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott at Metro
Center, 775 12th Street NW, Washington, DC
20005.
Contact Person: Rebecca H. Johnson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18C, Bethesda,
MD 20892, 301–594–2771, johnsonrh@
nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of K99/R00 Applications.
Date: July 22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Circle Hotel, 1500 New
Hampshire Avenue NW, Washington, DC
20036.
Contact Person: Lisa A. Dunbar, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN12, Bethesda, MD
20892, 301–594–2849, dunbarl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
E:\FR\FM\31MYN1.SGM
31MYN1
Federal Register / Vol. 84, No. 105 / Friday, May 31, 2019 / Notices
Dated: May 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–11337 Filed 5–30–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Notice of Issuance of Final
Determination Concerning
Electroenceplogram (EEG) Cutaneous
Electrodes
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of final determination.
AGENCY:
This document provides
notice that U.S. Customs and Border
Protection (‘‘CBP’’) has issued a final
determination concerning the country of
origin of Rhythmlink International
L.L.C’.s, Electroencephalogram (EEG)
Cutaneous Electrodes. Based upon the
facts presented, CBP has concluded in
the final determination that the last
substantial transformation of the
Electroencephalogram (EEG) Cutaneous
Electrode Product occurs in the United
States.
DATES: The final determination was
issued on May 24, 2019. A copy of the
final determination is attached. Any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of
this final determination within July 1,
2019.
khammond on DSKBBV9HB2PROD with NOTICES
SUMMARY:
attachment of a lead wire to the U.S.
origin Electroencephalogram (EEG)
Cutaneous Electrodes by crimping or
gluing in China is not a substantial
transformation. Therefore, the last
substantial transformation of the
Rhythmlink Electroencephalogram
(EEG) Cutaneous Electrode product
occurs in the United States.
Section 177.29, CBP Regulations (19
CFR 177.29), provides that notice of
final determinations shall be published
in the Federal Register within 60 days
of the date the final determination is
issued. Section 177.30, CBP Regulations
(19 CFR 177.30), provides that any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of a
final determination within 30 days of
publication of such determination in the
Federal Register.
Dated: May 24, 2019.
Craig T. Clark,
Acting Executive Director, Regulations and
Rulings, Office of International Trade.
HQ H300745
May 24, 2019
OT:RR:CTF:VS H300745 RSD
Origin
David S. Robinson
Nexsen Pruet, PLLC
4141 Parklake Avenue
Suite 200
Raleigh, NC 27612
RE: U.S. Government Procurement; Title
III, Trade Agreements Act of 1979 (19
U.S.C. § 2511); Subpart B, Part 177, CBP
Regulations; Electroencephalogram
(EEG) Cutaneous Electrodes; Substantial
Transformation
CATEGORY:
FOR FURTHER INFORMATION CONTACT:
Dear Mr. Robinson:
Robert Dinerstein, Valuation and
Special Programs Branch, Regulations
and Rulings, Office of International
Trade (202–325–0132).
SUPPLEMENTARY INFORMATION: Notice is
hereby given that on May 24, 2019,
pursuant to subpart B of part 177,
Customs and Border Protection (CBP)
Regulations (19 CFR part 177, subpart
B), CBP issued a final determination
concerning the country of origin of the
Electroencephalogram (EEG) Cutaneous
Electrodes which may be offered to the
United States Government under an
undesignated government procurement
contract. This final determination, in
HQ H300745, was issued at the request
of Rhythmlink International, L.L.C.
under procedures set forth at 19 CFR
part 177, subpart B, which implements
Title III of the Trade Agreements Act of
1979, as amended (19 U.S.C. 2511–18).
In the final determination, CBP
concluded that the assembly and
This is in response to your letter,
dated September 10, 2018, requesting a
final determination on behalf of
Rhythmlink International, LLC.
(Rhythmlink) pursuant to subpart B of
Part 177 of the U.S. Customs and Border
Protection (CBP) Regulations (19 C.F.R.
Part 177).
This final determination concerns the
country of origin of various selfadhesive cutaneous electrode products.
As a U.S. importer, Rhythmlink is a
party-at-interest within the meaning of
19 C.F.R. § 177.22(d)(1) and is entitled
to request this final determination.
Samples of three versions of the product
have been submitted for our review.
VerDate Sep<11>2014
16:42 May 30, 2019
Jkt 247001
FACTS:
Rhythmlink is headquartered in
Columbia, North Carolina and
manufactures and distributes medical
devices. It seeks a country of origin
determination for the purposes of
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
25297
United States government procurement
for a line of Electroencephalogram (EEG)
Electrode products.
An EEG is a test that detects electrical
activity in the brain using electrodes
attached to the scalp. Doctors use an
EEG test to help diagnose certain
neurological conditions, such as
epilepsy and sleep disorders. The EEG
electrode allows for a physical
connection between a patient and
medical diagnostic equipment. To use
the EEG electrodes, the patient’s scalp is
cleaned, and the cutaneous electrodes
are attached to the patient’s skin using
a small amount of an adhesive
conductive gel or paste, either to record
physiological signals (e.g., the
electroencephalogram) or to apply
electrical stimulation. To accomplish its
function, the EEG electrode uses a glassfilled ABS plastic mold with a silverchloride coating. It is designed and
manufactured to specifications as a U.S.
Food and Drug Administration (FDA)
medical regulated ‘‘cutaneous
electrode’’, mainly for the recording of
its electrical conductor function.
Rhythmlink’s EEG electrodes are
disposable.
The product comes in varying
lengths/styles and the end user can
customize the color of the connecting
wire. The electrodes’ function is
common to all lengths and is unchanged
by the color of the connecting wire.
There are three EEG electrode products
that have common construction and
function: the Disposable Slim Cup, the
Disposable Deep Cup, and Disposable
Webb.
Rhythmlink conducts all engineering
and design of the EEG electrodes in the
United States. The actual production
and manufacture of the cutaneous
electrodes is outsourced to a third party
subcontractor located in the United
States. The single-source manufacturer
supplies the finished EEG electrodes to
Rhythmlink, marked ‘‘Country of
Origin: USA.’’ The manufacturer must
further certify that, ‘‘This uniform silver
coating applied to precision molded
products enhances the mechanical and
electrical performance of the finished
electrode products so they can meet or
exceed applicable AAMI Standards.’’
The fully assembled, packaged end
product for medical use consists of five
elements: the cutaneous electrode, the
lead wire, a miniscule amount of crimp
or glue, a heat shrink tube, and
packaging. The subcontractor-supplied
cutaneous electrodes are shipped from
the United States to China where a lead
wire is attached. You state that the lead
wire acts as an electrical conductor that
transfers low voltage electrical signals
from the electrode to medical diagnostic
E:\FR\FM\31MYN1.SGM
31MYN1
]]>Agencies
[Federal Register Volume 84, Number 105 (Friday, May 31, 2019)]
[Notices]
[Pages 25296-25297]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-11337]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Review of NIGMS R25 Innovative
Programs to Enhance Research Training (IPERT) Applications.
Date: July 11, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Marriott at Metro Center, 775 12th Street NW,
Washington, DC 20005.
Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, Natcher Building,
Room 3AN18C, Bethesda, MD 20892, 301-594-2771,
[email protected].
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Review of K99/R00 Applications.
Date: July 22, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Dupont Circle Hotel, 1500 New Hampshire Avenue NW,
Washington, DC 20036.
Contact Person: Lisa A. Dunbar, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN12, Bethesda, MD 20892, 301-594-2849, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859, Biomedical Research and
Research Training, National Institutes of Health, HHS)
[[Page 25297]]
Dated: May 24, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-11337 Filed 5-30-19; 8:45 am]
BILLING CODE 4140-01-P
